Friedreich s Ataxia

Friedreich's Ataxia (FRDA) is a rare, inherited, life-shortening neurological disorder that affects movement, balance, coordination, speech and vision. It's caused by a mutation in a gene on chromosome 9, which encodes a protein called frataxin that is deficient or absent in people with the condition. Symptoms usually start in early childhood and include a wide variety of physical, cognitive and emotional problems. FRDA affects 1 in every 50,000 people and is one of the most common hereditary ataxias. Current treatments focus on managing symptoms and include physical and occupational therapies, medications and assistive devices. Growing research and promising gene therapy trials are offering hope for the future for those affected by FRDA.

← Journal of Genetic Engineering

Related Articles

1 journal(s) found

Genetic Engineering

ISSN: 2694-1198
Type: Open Access Journal
Editor-in-Chief: Tao Xu, Joslin Diabetes Center and Harvard Medical School
Journal of Genetic Engineering is an international peer reviewed journal that accepts and publishes manuscripts in the form of original Research, Review, Literature review, Conference proceedings, Case reports, Short communication, Thesis, Letter to editor and Editorials covering all the areas of genetic engineering with new principles.